BU-NOT-SET

CONTACT US
Recipharm launches new virtual inspection and audit tool for customers, in light of COVID-19 outbreak
  • Manufacturing
Eyes
Insight
Recipharm 25 years
  • Corporate
24 years
Brochure
API product list
  • Drug substance
white pills
Fact sheet
Inhibition of 19S proteasome deubiquitinating activity in Schistosoma mansoni affects viability, oviposition, and structural changes
  • Drug substance
Eyes
Insight
The demand for antibiotics and its impact on the pharmaceutical industry since the outbreak of COVID-19
  • Industry trends
Eyes
Insight
Women in leadership
  • Corporate
Eyes
Insight
The state of the oral solid dose development and manufacturing market
  • Drug product
Eyes
Insight
Characterising APIs is Essential for Combo Drug Formulations
  • Drug substance
Eyes
Insight
Outsourcing stability testing
  • Analytical chemistry
Eyes
Insight
Insight
  • Biologics
  • Manufacturing
Lyophilisation: Key to overcoming stability hurdles for complex therapeutics
Insight
  • Drug product
  • Manufacturing
Key trends shaping high-potency API manufacturing in 2026
Webinar
  • Drug product
  • Manufacturing
Webinar | High potent API manufacturing: Strategies, safety & scale-up
Insight
  • Biologics
  • Drug product
Advancing malaria vaccine innovation through collaborative science
Insight
  • Analytical chemistry
  • Drug product
Adapting analytical testing to increasing development complexity
Insight
  • Drug product
  • Manufacturing
Navigating high potency OSD manufacturing
Insight
  • Manufacturing
  • Sustainability
Sustainable drug delivery systems: Collaborative innovation to shrink pharma’s packaging footprint
eBook
  • Drug product
  • Manufacturing
ReciPredict - How value by design can bring your drug to market faster
eBook
  • Biologics
  • Manufacturing
Enhancing stability for next-generation therapeutics with lyophilisation